[1]赵磊 梁兆光.导管消融术后心房颤动复发的危险因素及预防[J].心血管病学进展,2019,(5):766-769.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.025]
 ZHAO LeiLIANG Zhaoguang.Risk Factors and Prevention of Atrial Fibrillation Recurrence after Catheterablation[J].Advances in Cardiovascular Diseases,2019,(5):766-769.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.025]
点击复制

导管消融术后心房颤动复发的危险因素及预防()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2019年5期
页码:
766-769
栏目:
综述
出版日期:
2019-08-25

文章信息/Info

Title:
Risk Factors and Prevention of Atrial Fibrillation Recurrence after Catheterablation
作者:
赵磊 梁兆光
(哈尔滨医科大学附属第一医院心内科,黑龙江 哈尔滨 150000)
Author(s):
ZHAO LeiLIANG Zhaoguang
(Department of CardiologyThe First Affiliated Hospital of Harbin Medical UniversityHarbin 150000 HeilongjiangChina)
关键词:
心房颤动导管消融复发预防
Keywords:
Atrial fibrillationCatheter ablationRecurrencePrevention
DOI:
10.16806/j.cnki.issn.1004-3934.2019.05.025
摘要:
心房颤动是临床上最常见的心律失常,与血栓栓塞风险的增加、心源性猝死及生活质量下降等密切相关。近年来心房颤动导管消融术逐渐成为心房颤动非药物治疗的一线手段,但仍有一些患者出现术后心房颤动复发。心房颤动复发的类型包括早期复发、晚期复发及远期复发,不同的复发类型存在不同的病理生理机制,但存在部分相似的危险因素。完善的术后患者管理及严格的危险因素控制是预防心房颤动复发的关键。现将分别探讨不同术后复发类型的病理机制及其危险因素,并结合心房颤动复发的预防进行综述。
Abstract:
Atrial fibrillation (AF) is the most common arrhythmia clinically, and closely related to increased risk of thromboembolism, sudden cardiac death and decreased quality of life. In recent years, catheter ablation has gradually become the first line of non-drug therapy for AF, but some patients still have recurrent AF after ablation. The types of AF recurrence include early recurrence, late recurrence and long-term recurrence, and there are different mechanisms in different types of AF, but some risk factors are similar. Good patient management and strict risk factors control are the key to prevent the recurrence of AF. In this paper, the mechanism and risk factors of different types of AF recurrence were discussed, and same of the prevention of AF

参考文献/References:

[1].Nattel S.New ideas about atrial fibrillation 50 years on[J].Nature, 2002, 415(6868):219-226.
[2].Calkins H,Reynolds MR,Spector P,et al.Treatment of atrial f ibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses[J].Circ Arrhythm Electrophysiol,2009,2(4):349-361.
[3].黄从新,张澍,黄德嘉,等.心房颤动:目前的认识和治疗的建议-2018[J].中国心脏起搏与心电生理杂志,2018,32(4):315-368.
[4].Joshi S,Choi AD,Kamath GS,et al.Prevalence, predictors, and prognosis of atrial fibrillation early after pulmonary vein isolation: findings from 3 months of continuous automatic ECG loop recordings[J].J Cardiovasc Electr, 2010, 20(10):1089-1094.
[5].Vizzardi E,Curnis A ,Latini MG,et al.Risk factors for atrial fibrillation recurrence:a literature review[J].J Cardiovasc Med, 2014,15(3):235-253.
[6].Nalliah CJ,Lim TW,Kizana E,et al.Clinical significance of early atrial arrhythmia type and timing after single ring isolation of the pulmonary veins[J].Europace, 2015,17(7):1038-1044.
[7].Cai L,Yin Y,Ling Z,et al. Predictors of late recurrence of atrial fibrillation after catheter ablation[J].Int J Cardiol, 2013,164(1):82-87.
[8].Bertaglia E,Stabile G, Senatore G,et al.Predictive value of early atrial tachyarrhythmias recurrence after circumferential anatomical pulmonary vein ablation[J].PACE,2005,28(5):366-371.
[9].Jason G,Paul K,Atul V,et al.Early recurrence of atrial tachyarrhythmias following radiofrequency catheter ablation of atrial fibrillation[J].PACE,2012,35(1):106-116.
[10].Liang JJ,Dixit S.Early recurrences during the blanking period after atrial fibrillation ablation[J].J Atr Fibrillation,2018,10(5):1-5.
[11].Nery PB,Belliveau D,Nair GM,et al.Relationship between pulmonary vein reconnection and atrial fibrillation recurrence: a systematic review and meta-analysis[J].JACC Clin Electrophysiol,2016,2(4):474-483.
[12].Hsieh MH,Tai CT,Lee SH,et al.The different mechanisms between late and very late recurrences of atrial fibrillation in patients undergoing a repeated catheter ablation[J].J Cardiovasc Electr,2006,17(3):231-235.
[13].Cheng Z,Deng H,Cheng K,et al.The amplitude of fibrillatory waves on leads aVF and V-1 predicting the recurrence of persistent atrial fibrillation patients who underwent catheter ablation[J].Ann Noninvas electro, 2013, 18(4):352-358.
[14].Balk EM,Garlitski AC,Alsheikh-Ali AA,et al.Predictors of atrial fibrillation recurrence after radiofrequency catheter ablation: a systematic review[J].J Cardiovasc Electr, 2010, 21(11):1208-1216.
[15].Ausma J,Wijffels M,Thoné F,et al. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat[J].Circulation, 1997, 96(9):3157-3163.
[16].Efremidis M,Letsas KP,Georgopoulos S,et al.Safety, long-term outcomes and predictors of recurrence following a single catheter ablation procedure for atrial fibrillation[J].Acta Cardiologica, 2018 Oct 10:1-6. doi: 10.1080/00015385.2018.1494114.
[17].Steinberg JS,Palekar R,Sichrovsky T,et al.Very long-term outcome after initially successful catheter ablation of atrial fibrillation[J].Heart Rhythm,2014,11(5):771-776.
[18].Fredersdorf S,Fenzl C,Jungbauer C,et al.Long-term outcomes and predictors of recurrence after pulmonary vein isolation with multielectrode ablation catheter in patients with atrial fibrillation[J].J Cardiovasc Med,2018,19(4):148-154.
[19].Weerasooriya R,Khairy P,Litalien J,et al.Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up?[J].J Am CollCardiol, 2011, 57(2):160-166.
[20].Gami AS,Hodge DO,Herges RM,et al.Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation[J].J Am Coll Cardiol, 2007, 49(5):565-571.
[21].Szymanski FM ,Filipiak J ,Platek E ,et al.Presence and severity of obstructive sleep apnea and remote outcomes of atrial fibrillation ablationsa long-term prospective,cross-sectional cohort study[J].Sleep Breath,2015,19(3):849-856.
[22].Hojo R,Fukamizu S,Miyazawa S ,et al.The relationship between obstructive sleep apnea and recurrence of atrial fibrillation after pulmonary vein isolation using a contact force-sensing catheter[J].Int J Cardiol,2019,54(3):209-215.
[23].Rattanawong P,Chenbhanich J,Vutthikraivit W,et al.A chromosome 4q25 variant is associated with atrial fibrillation recurrence after catheter ablation: a systematic review and meta-analysis[J].J Atr Fibrillation, 2018, 10(6):1666.
[24].Jiang H ,Wang W,Wang C,et al.Association of pre-ablation level of potential blood markers with atrial fibrillation recurrence after catheter ablation: a meta-analysis[J].Europace,2017,19(3):392-400.
[25].Calkins H,Hindricks G,Cappato R,et al.2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation[J].Heart Rhythm,2017,14(10):e275.
[26].Link MS,Ha?ssaguerre M,Natale A.Ablation of atrial fibrillation: patient s election, periprocedural anticoagulation, techniques, and preventive measures after ablation[J].Circulation, 2016,134(4):339-352.
[27].Pathak RK,Middeldorp ME,Lau DH ,et al.Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study[J].J Am Coll Cardiol, 2014, 64(21):2222-2231.
[28].Rordorf R ,Savastano S,Gandolfi E,et al.Pharmacological therapy following catheter ablation of atrial fibrillation[J].J Cardiovasc Med,2012,13(1):9-15.
[29].Koyama T,Tada H,Sekiguchi Y,et al.Prevention of atrial fibrillation recurrence with corticosteroids after radiofrequency catheter ablation: a randomized controlled trial[J].J Am Coll Cardiol,2010,56(18):1463-1472.
[30].Deftereos S,Giannopoulos G,Efremidis M,et al.Colchicine for prevention of atrial fibrillation recurrence after pulmonary vein isolation: mid-term efficacy and effect on quality of life[J].Heart Rhythm,2014,11(4):620-628.

相似文献/References:

[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
 HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(5):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
 DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(5):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
 ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(5):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[4]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
 ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(5):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[5]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
 HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(5):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[6]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
 WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(5):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[7]徐小东,综述,杨东辉,等.决奈达隆治疗心房颤动的现状及展望[J].心血管病学进展,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
 XU Xiaodong,YANG Donghui.Status and Prospect of Dronedarone in Treating Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(5):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
[8]张莎,储国俊,吴弘.经导管左心耳封堵术的临床应用进展[J].心血管病学进展,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
 ZHANG Sha,CHU Guojun,WU Hong.Clinial Application Advances in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
[9]汪俊,杨浩.心房颤动射频消融的术式演变[J].心血管病学进展,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
 WANG Jun,YANG Hao.Evolution of Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
[10]赵璐,苏立.心房颤动与离子通道重构研究进展[J].心血管病学进展,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
 ZHAO Lu,SU Li.Research Progress of Atrial Fibrillation and Ion Channel Remodeling[J].Advances in Cardiovascular Diseases,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
[11]吴彤 高东来.心房颤动合并心力衰竭的射频消融治疗[J].心血管病学进展,2019,(5):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]
 WU TongGAO Donglai.Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2019,(5):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]
[12]辛小宇 梁兆光.心房颤动导管消融围术期抗凝治疗研究进展[J].心血管病学进展,2020,(8):809.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.007]
 XIN XiaoyuLIANG Zhaoguang.Perioperative Anticoagulation for Atrial Fibrillation Catheter Ablation[J].Advances in Cardiovascular Diseases,2020,(5):809.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.007]
[13]赵灿 吴永全.基于环肺静脉隔离的房颤导管消融策略选择治疗进展[J].心血管病学进展,2020,(12):1234.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.003]
 ZHAO Can,WU Yongquan.Catheter Ablation Strategies for Atrial Fibrillation Based on Circumferential Pulmonary Vein Isolation[J].Advances in Cardiovascular Diseases,2020,(5):1234.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.003]
[14]刘玉辉 王盼盼 陈椿.心房颤动性心肌病临床研究进展[J].心血管病学进展,2020,(12):1238.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.004]
 LIU Yuhui,WANG Panpan,CHEN Chun.Atrial Fibrillation-induced Cardiomyopathy[J].Advances in Cardiovascular Diseases,2020,(5):1238.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.004]
[15]白金龙 李洪仕 蔡衡.非瓣膜性心房颤动导管消融术后抗凝策略的研究进展[J].心血管病学进展,2021,(1):30.[doi:10.16806/j.cnki.issn.1004-3934.201.01.000]
[16]那丞 黄织春.干预自主神经对心房颤动影响的研究进展[J].心血管病学进展,2021,(1):30.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
 NA Cheng,HUANG Zhichun.Effect of Autonomic Nerve Intervention on Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2021,(5):30.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
[17]徐尧 蔡衡 李洪仕.心房颤动合并心力衰竭的导管消融治疗[J].心血管病学进展,2021,(4):322.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.009]
 XU Yao,CAI Heng,LI Hongshi.Role of Radiofrequency Ablation in Patients with Atrial Fibrillation and Heart Failure[J].Advances in Cardiovascular Diseases,2021,(5):322.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.009]
[18]袁明 谢瑞芹.导管消融对心房颤动患者生活质量影响的研究进展[J].心血管病学进展,2021,(10):884.[doi:10.16806/j.cnki.issn.1004-3934.2021.10.005]
 YUAN MingXIE Ruiqin.Effect of Catheter Ablation on Quality of Life in patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2021,(5):884.[doi:10.16806/j.cnki.issn.1004-3934.2021.10.005]
[19]邹永伟 胡小恋.左房低电压与心房颤动相关性的研究进展[J].心血管病学进展,2022,(3):211.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
 ZHOU Yongwei,H U Xiaolian.The Correlation Between Left Atrial Low-Voltage Area and Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2022,(5):211.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
[20]李珂 赵海娟 赵耀 黄松群 郭志福.肥厚型心肌病合并心房颤动的导管消融[J].心血管病学进展,2022,(5):399.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.004]
 LI Ke,ZHAO Haijuan,ZHAO Yao,et al.Catheter Ablation of Hypertrophic Cardiomyopathy with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2022,(5):399.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.004]

更新日期/Last Update: 2019-12-24